TrialJournal of bone and mineral metabolism2020

Evocalcet in patients with primary hyperparathyroidism: an open-label, single-arm, multicenter, 52-week, dose-titration phase III study.

Yasuhiro Takeuchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.